[Retracted] Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma

Table 6

Comparison of quality of life scores between the two groups (, points).

Group	Physiological status		Social ability and family status		Emotional status		Functional status
	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Observation group ()		^a		^a		^a		^a
Control group ()		^a		^a		^a		^a
t	0.195	11.211	0.447	3.989	0.456	14.814	1.075	13.720
P	0.846	<0.001	0.656	<0.001	0.649	<0.001	0.286	<0.001

Note: compared with before treatment in the same group, ^a.